Shezad Malik Law Firm Dr Shezad Malik Law Firm has offices based in Fort Worth and Dallas and represents people who have suffered catastrophic and serious personal injuries including wrongful death, caused by the negligence or recklessness of others. We specialize in Personal Injury trial litigation and focus our energy and efforts on those we represent.

Articles Tagged with Taxotere

Taxotere Hair Loss lawsuits in settlement discussion. According to sources, the Taxotere hair loss lawsuits may be in preliminary stages of settlement talks.

axotere Hair Loss lawsuits in settlement discussion.

Taxotere Hair Loss lawsuits in settlement discussion. Taxotere use in breast cancer chemotherapy associated with increased risk of permanent and horrendous hair loss.

The judge overseeing the multidistrict litigation in the Taxotere chemotherapy drug products liability litigation has ordered plaintiff attorneys to file information about all pending and anticipated claims “so that “claimants may have the opportunity to participate in any eventual resolution process.”

Another Louisiana Taxotere hair loss lawsuit has been filed. The lawsuit was filed in the U.S. District Court for the Eastern District of Louisiana against Sanofi-Aventis over the failure to warn about the side effects of Taxotere.

Louisiana Taxotere hair loss lawsuit filed

Taxotere use in breast cancer chemotherapy associated with increased risk of permanent and horrendous hair loss.

According to Iris Guidry, in her Louisiana Taxotere hair loss lawsuit, claims that the chemotherapy drug Taxotere caused her to suffer permanent and horrendous hair loss, which is not associated with other effective breast cancer treatments.

Guidry claims that Sanofi-Aventis withheld critical information and warnings from patients and doctors about the risk that patients may experience permanent hair loss from Taxotere.

Hair Loss is common after Chemotherapy

Temporary hair loss is to be expected after chemotherapy, and the drug manufacturer claimed that hair grows back after Taxotere use. But, Guidry alleges that since she received breast cancer treatments involving Taxotere in 2011, she has continued hair loss side effects.

Taxotere Hair Loss Lawsuits

Many Taxotere failure to warn lawsuits are filed across the U.S., claiming that Sanofi-Aventis did not adequately disclose the risks of permanent and horrendous hair loss, providing reckless marketing statements. The lawsuits also claim that the drug manufacturer actively encouraged doctors to use Taxotere despite its risks and despite the availability of other, safer cancer treatments.

Continue reading

Taxotere lawsuits on the risePlaintiffs’ lawyers have requested a new multidistrict litigation for lawsuits alleging that Sanofi SA’s chemotherapy drug Taxotere can cause permanent hair loss in women, particularly those being treated for breast cancer.

In a July 22 motion, lawyers for two plaintiffs asked the U.S. Judicial Panel on Multidistrict Litigation to send Taxotere litigation – currently comprising 33 lawsuits in 16 federal courts – to the U.S. District Court for the Eastern District of Louisiana.

A growing number of lawsuits filed against the makers of Taxotere allege that the company failed to warn patients that Taxotere may cause permanent hair loss. The lawsuits also claim that the drug manufacturer actively encouraged doctors to use Taxotere despite its risks and despite the availability of other, safer cancer treatments.

Taxotere LawsuitsAn Illinois woman filed a lawsuit against the makers Taxotere. She claims the controversial breast cancer drug caused her to develop permanent hair loss, a condition often referred to as permanent alopecia.

The lawsuit was filed in the U.S. District Court for the Northern District of Illinois on June 28 by Renita Johnson. Johnson alleges that the drug maker knew or should have known that women may be left with permanent alopecia after using Taxotere, but provided misleading and false information that suggested hair typically regrows.

Johnson points to a 2005 study which found that one out of every 10 patients treated with Taxotere suffered hair loss that lasted up to 10 years and five months, and in some cases longer.

Chemotherapy can cause permanent hair loss especially in the treatment of breast cancer . This hair loss can be permanent and devastating. Sanofi-Aventis, the maker of a popular intravenous chemotherapy drug, Taxotere, is under fire in several lawsuits claiming that Taxotere, may cause permanent hair loss or baldness (Alopecia) in women.

Taxotere Permanent Baldness AttorneyRecently, Hattie Carson filed her claim of Taxotere baldness from chemotherapy side effects, in the U.S. District Court for the Northern District of Ohio. Carson, claims that Sanofi-Aventis failed to adequately warn female breast cancer patients and doctors about the risk of Taxotere permanent baldness.

According to Carson, she was diagnosed with breast cancer in 2004, and underwent Taxotere chemotherapy. Carson was diagnosed with permanent hair loss, after her hair did not grow back after 6 months.

Taxotere Baldness

Baldness is a common and emotionally devastating side-effect of chemotherapy. Scalp, pubic and axillary hair may be lost, as well as eyebrows and eyelashes, but in most cases, the hair loss is temporary and usually reversible, with complete hair regrowth within the 3–6 months following the chemotherapy cycles.

Recently, in the past few years, many case reports of permanent, irreversible post-chemotherapy baldness, no hair growth after 6 months have been described from Taxotere.

What is Taxotere?

Taxotere (docetaxel) is a cancer medication that interferes with the growth and spread of cancer cells in the body. Taxotere is used to treat breast cancer, lung cancer, prostate cancer, stomach cancer, and head/neck cancer.

Taxotere is a cancer drug given in a cocktail of chemotherapy drugs, for the treatment of breast cancer. Taxotere was approved by the FDA in May 1996 for the treatment of patients with advanced or metastatic breast cancer after prior chemotherapy attempts had failed.

Carson claims in her lawsuit, “Although alopecia is a common side effect related to chemotherapy drugs, permanent alopecia is not. Defendants, through its publications and marketing material, misled Plaintiff, the public, and the medical community to believe that, as with other chemotherapy drugs that cause alopecia, patients’ hair would grow back.”

Sanofi-Aventis Warned About Taxotere Baldness

Carson alleges that Sanofi-Aventis warned doctors and patients in Europe in 2005 and in Canada 2012 about the risks of permanent hair loss from Taxotere side effects, but failed to provide such warnings to the U.S. patients and doctors until January 2016. Read the FDA Warning label change in January 2016.

Taxotere Baldness “Disfiguring”

According to Carson, Taxotere baldness is disfiguring for women, and that it caused her to suffer great mental anguish, economic damages and that the psychological damage was extensive enough that it caused a loss of work or inability to work.

Taxotere “I look like an 80-year-old, ugly old man”

Taxotere baldness injured women are now warning other permanent hair loss victims in social media venues. According to a 2010 article in the Globe and Mail, “I had a normal head of hair and I am now completely bald,” said Cynthia MacGregor, 50, of Montreal, who has been diagnosed with alopecia universalis, a loss of all body hair.

According to Shirley Ledlie, 51, of Brittany, France, said: “It’s like having ‘I am a cancer sufferer’ tattooed on your forehead. … I look like an 80-year-old, ugly old man.”

Taxotere affected permanent balding women from Canada, the United States, the United Kingdom and France are calling themselves the Taxotears. They include one Taxoterrorist, the nickname for Ms. Ledlie, who posted pictures of her balding head on the Facebook page of the pharmaceutical company.

“We want every woman who’s been offered Taxotere to know it is a possibility, so it is her choice whether to take the risk or not,” Ms. Ledlie said.

Continue reading

Contact Information